| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |